Ambipar wins US court backing, the group behind Ambipar stock

Published on 10/01/2026 at 13:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Ambipar, behind Ambipar stock, won US recognition on September 28, 2026. Market cap was BRL 316.7 million. Results are due November 18, 2026.

Ambipar, BRAMBPACNOR6, Illustration mit AI erstellt.

Ambipar (BRAMBPACNOR6) won recognition for its Brazilian restructuring in a US court on September 28, 2026, while the group behind Ambipar stock moves toward a coordinated Chapter 15 process. The decision suspended the Chapter 11 case of Ambipar Emergency Response and kept the Brazilian proceedings at the center of the reorganization.

US court backs Brazilian process

According to Estadao on September 28, 2026, the US Bankruptcy Court for the Southern District of Texas recognized the judicial recovery proceeding in Rio de Janeiro as the main foreign proceeding under Chapter 15. The ruling also suspended the Chapter 11 case involving Ambipar Emergency Response.

The legal shift matters because Chapter 15 allows a US court to recognize and coordinate a restructuring led in another country. The decision does not end the US case immediately: its termination is expected to be requested after a final US decision recognizes the Brazilian recovery plan.

Debt restructuring remains central

C-Level reported on September 28, 2026, that Ambipar's debt stood at BRL 13.3 billion. The same report said holders of 53.8 percent of green notes worth USD 1.05 billion had signed a creditor agreement carrying annual interest rates of 9.9 percent and 10.9 percent.

The comparison between the BRL 13.3 billion debt figure and the BRL 316.7 million market capitalization shows why court coordination is the dominant issue for the equity story. The legal framework can organize negotiations, but it does not by itself restore earnings, margins or regular financial reporting.

B3 trading shows a distressed profile

Ambipar stock was quoted at BRL 0.19 on B3 on September 30, 2026, with a previous close of BRL 0.19. The same dated market page showed a 52-week range from BRL 0.14 to BRL 8.87 and market capitalization of BRL 316.7 million.

Investing.com identifies Ambipar's ticker as AMBP3, confirms its B3 listing and names November 18, 2026, as the next earnings date. For investors, that date is a concrete checkpoint because the company has been operating through a court-supervised restructuring while the market continues to price the shares at a fraction of the 52-week high.

Restructuring sets the next test

The US ruling gives Ambipar a clearer cross-border legal route, but the next measurable test is the Brazilian recovery plan and its treatment of the company's BRL 13.3 billion debt. The November 18, 2026, earnings date may provide the next formal update on operations and financial reporting.